The misconception that women are just “carriers” has persisted for decades. We aren’t given the same access to care. Some of us aren’t diagnosed until adulthood — after years of unexplained bleeding, ...

Researchers have made a groundbreaking discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with ...

Bleeding disorders refer to a group of conditions characterized by difficulties in blood clotting, leading to prolonged bleeding or excessive bruising. These disorders can be congenital (inherited ...

Researchers at the University of North Carolina (UNC) have discovered that adenovirus, a common virus that causes colds and ...

The hemophilia market is expected to experience significant growth due to advancements in gene therapy, innovative treatments, and an increasing focus on personalized medicine. Rising awareness and ...

[1–2] Failure of these regulatory pathways could result in either abnormal clot formation or excessive bleeding ... Individualized healthcare in clotting disorders has been, and will continue ...

UC San Diego Health is one of a few health care systems on the West Coast to offer a new gene therapy for hemophilia B, a bleeding disorder that prevents blood from clotting properly. The FDA ...

Blood thinners prescribed after blood clots in leg or lung initially increase the risk of bleeding, especially in women and ...

The trial was stopped early by the recommendation of the Data Monitoring Committee due to an overwhelming reduction in bleeding compared ... fibrillation because blood clots form in the heart ...

Four years after receiving Hemgenix in a Phase 3 trial, bleeding rates and the use of replacement therapy are low for men ...

Explore the genetic findings in 527 rare bleeding disorder cases, presented at EAHAD 2024, shedding light on novel variants.